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Abstract
Background Data comparing outcomes following cholecystectomy and cholecystostomy tube placement (CTP) in elderly pa-
tients are lacking. We aimed to compare the post-procedural outcomes between cholecystectomy and CTP in elderly patients with 
acute cholecystitis.
Methods We performed a retrospective, population-based analysis using the National Inpatient Sample for the period 2000–
2014. Patients ≥ 65 years old admitted with a primary diagnosis of acute cholecystitis and who underwent either cholecystectomy 
or CTP during their hospitalization were included. Multivariable linear and logistic regression models were used to analyze post-
procedural complications, mortality, length of stay, and total charges. The effect of procedure type on patient outcomes, stratified 
by acalculous and calculous cholecystitis, was also performed.
Results A total of 200,915 patients were included, of which 7516 underwent CTP and 193,399 underwent cholecystectomy. The 
median age of patients undergoing CTP and cholecystectomy was 80 (IQR 73–87) and 75 (IQR 70–81), respectively. Patients 
undergoing CTP were more likely to have post-procedural infection (OR 2.25; 95% CI 2.07, 2.45), bleeding (OR 1.28; 95% CI 
1.19, 1.37), and inpatient mortality (OR 9.27; 95% CI 7.95, 10.81). On average, CTP patients stayed 1.25 days longer (95% CI 
1.14, 1.37) in hospital after the procedure. The benefits of cholecystectomy were consistent in patients with acalculous and 
calculous cholecystitis.
Conclusions Elderly patients with both acalculous and calculous acute cholecystitis managed with CTP have higher incidences of 
post-procedural morbidity and mortality, and longer post-procedure length of hospital stay, as compared to cholecystectomy. 
Unless prohibitive surgical risks exist, elderly patients with acute cholecystitis should undergo cholecystectomy.
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Introduction
Acute cholecystitis is a common disease that affects up to
20% of all patients with symptomatic gallstone disease.1 In
the USA, gallstones are the fifth leading diagnosis for
emergency department visits, resulting in a significant clin-
ical and economic burden.2 Generally, laparoscopic chole-
cystectomy is the treatment of choice, as it is considered
effective and safe with low rates of morbidity and
mortality.3,4
As the progressive aging of the US population occurs, it
is expected that the number of elderly patients with acute
cholecystitis will also increase. Elderly patients often have
significant comorbidities and age-related changes that lead
to a decreased physiologic reserve, particularly during
physical stress such a surgical intervention. Compared to
surgical resection, cholecystostomy tube placement (CTP)
presents as an attractive, less invasive alternative proce-
dure in these patients.5–8 Current guidelines put emphasis
on the severity of the disease and recommend urgent gall-
bladder drainage with CTP in patients with severe acute
cholecystitis (grade III) associated with organ system
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dysfunction.9 Unfortunately, data analyzing outcomes fol-
lowing cholecystectomy or CTP in elderly patients with
acute cholecystitis are conflicting.10–18
We hypothesized that elderly patients undergoing CTP
would have worse post-operative outcomes, compared to
those undergoing cholecystectomy. Therefore, we aimed to
compare the post-procedural outcomes, length of stay, and
charges between CTP and cholecystectomy in elderly patients
with acute cholecystitis.
Material and Methods
A cohort of patients was identified using the National
Inpatient Sample (NIS) database between January 1, 2000
and December 31, 2014. The NIS is the largest publically
available all-payer health care database in the USA and
includes over seven million hospitalizations from 1000
hospitals each year, representing a 20% stratified sample
of all hospital discharges in the USA. Eligible patients
were identified using International Classification of
Disease, 9th revision, Clinical Modification (ICD-9-CM)
diagnostic and procedural codes.
Patients ≥ 65 years old admitted with primary diagnosis
of acute cholecystitis (ICD-9-CM 574.0–574.91 and
575.0–575.12) who underwent CTP (51.0–51.03) or cho-
lecystectomy (51.2–51.24) during non-elective hospital
admissions were eligible for inclusion. Patients with
acalculous cholecystitis were identified using the codes
575.0, 575.1, and 575.10. Patients who had an unknown
or missing discharge disposition (n = 566) were excluded
from the analysis.
Surgical outcomes of interest were post-operative compli-
cations during the index hospitalization, discharge disposition
(including inpatient mortality), length of stay, and total hospi-
tal charges. Post-operative complications included venous
thromboembolism (415.11, 453.40–453.42, and V12.51),
wound complications (998.13, 998.30–998.32, and 998.83),
infection (54.91, 86.04, 567.22, 569.5, 995.9–995.99, 996.64,
998.5–998.59, and 999.3–999.39), bleeding (99.0–99.09,
998.11, and 998.12), and shock (998.0–998.09). A composite
complication (i.e., at least one post-operative complication)
was also analyzed.
Comorbidities of interest included hypertension (401–
401.9 and 402–402.91), primary and secondary diabetes
(249–249.91 and 250–250.93), obesity (278–278.8), renal in-
sufficiency (585–585.9), coronary artery disease (414–414.9),
peripheral vascular disease (443–443.9), cardiac failure (410–
410.9, 428–428.9), renal failure (38.95, 39.95, 584–584.9,
586, and V45.11), respiratory failure (31.1–31.29, 96.04,
96.05, 96.7–96.72, and 799.1), chronic obstructive pulmonary
disease (COPD) (491–492.8), and sleep apnea (327.23).
Statistical Analysis
Patient and hospital characteristics were compared across pro-
cedures using chi-square and Wilcoxon-Mann-Whitney tests,
where appropriate. Unadjusted, bivariate analyses of compli-
cations, discharge disposition, length of stay, and hospital
charges across procedures were conducted using chi-square
and Wilcoxon-Rank-Sum tests.
Multivariable analyses on the effect of CTP, compared to
cholecystectomy, were performed using logistic, generalized
logistic, and linear regression models, where appropriate. All
models were adjusted for sex, race/ethnicity, comorbidities,
type of cholecystitis, primary insurance, household income,
hospital region, teaching status, and size. Age was modeled
as a restricted cubic spline in all adjusted models.
Additionally, the effect of acalculous cholecystitis, com-
pared to calculous cholecystitis, on the procedure/patient out-
come relationships was also assessed by including interaction
terms in the multivariable models described above. A Wald
chi-square test was used to assess if the effect was different
across acalculous status.
All analyses were performed using SAS software version
9.4 (SAS Inc., Cary, NC), and a p value < 0.05 was considered
significant for all the statistical methods.
Results
A total of 200,915 patients were included, of which 7516
underwent CTP and 200,915 cholecystectomy. The median
age of patients undergoing CTP and cholecystectomy was
80 (IQR 73–87) and 75 (IQR 70–81), respectively (p <
0.0001). Patients undergoing CTP had higher prevalence of
comorbidities such as renal insufficiency, coronary artery dis-
ease, peripheral vascular disease, COPD, respiratory failure,
cardiac failure, and renal failure (Table 1). No difference was
seen in the time between admission and CTP (median 2 days,
IQR 1–3 days) or cholecystectomy (median 2 days, IQR 1–
3 days).
CTP was associated with higher incidences of infectious
complications (13.3 vs. 4.5%, p < 0.0001), bleeding (17.1 vs.
9.5%, p < 0.0001), and inpatient mortality (4.7 vs. 1.2%, p <
0.0001) (Table 2).
After adjusting for type of cholecystitis, patient demo-
graphics, comorbidities, and hospital characteristics, patients
undergoing CTP were significantly more likely to have post-
procedural infection (OR 2.25; 95% CI 2.07, 2.45), bleeding
(OR 1.28; 95% CI 1.19, 1.37), and inpatient mortality (OR
9.27; 95% CI 7.95, 10.81). On average, CTP patients stayed
1.25 days longer after the procedure (95% CI 1.14, 1.37) in
hospital (Table 3).
Patients with both acalculous and calculous cholecystitis
had worse post-procedural outcomes after CTP (Table 4).





Cholecystectomy N = 193,399 Cholecystostomy N = 7516
Sex, n (%)
Male 89,759 (46.4) 4033 (53.7)
Female 103,557 (53.6) 3483 (46.3)
Acalculous cholecystitis 19,827 (10.3) 3449 (45.9)
Age, in years, median (IQR) 75 (70–81) 80 (73–87)
Race/ethnicity, n (%)
Non-Hispanic White 124,970 (77.5) 4991 (76.2)
Non-Hispanic Black 10,407 (6.5) 624 (9.5)
Hispanic 16,862 (10.5) 566 (8.6)
Other 9107 (5.6) 369 (5.6)
Missing 32,053 966
Presence of comorbidities, n (%)
Hypertension 115,424 (59.7) 3929 (52.3)
Diabetes 51,608 (26.7) 2523 (33.6)
Obesity 17,726 (9.2) 662 (8.8)
Renal insufficiency 15,514 (8.0) 1429 (19.0)
Coronary artery disease 49,758 (25.7) 2725 (36.3)
Peripheral vascular disease 6696 (3.5) 508 (6.8)
Chronic obstructive pulmonary disease 4616 (2.4) 276 (3.7)
Sleep apnea 4430 (2.3) 263 (3.5)
Respiratory failure 6500 (3.4) 329 (4.4)
Cardiac failure 24,164 (12.5) 2368 (31.5)
Renal failure 14,782 (7.6) 1665 (22.2)
Primary insurance, n (%)
Public 173,062 (89.6) 6950 (92.6)
Private 17,297 (9.0) 460 (6.1)
Other/self-pay 2696 (1.4) 95 (1.3)
Household income, n (%)
Low 45,325 (23.9) 1688 (22.9)
Medium 50,006 (26.4) 1715 (23.3)
High 48,091 (25.4) 1905 (25.9)
Highest 46,091 (24.3) 2050 (27.9)
Hospital region, n (%)
Northeast 35,723 (18.5) 2589 (34.5)
Midwest 40,883 (21.1) 1689 (22.5)
South 78,221 (40.5) 2102 (28.0)
West 38,572 (19.9) 1136 (15.1)
Hospital location, n (%)
Rural, non-teaching 28,845 (15.0) 456 (6.1)
Urban, non-teaching 97,490 (50.5) 2305 (30.7)
Urban, teaching 66,547 (34.5) 4743 (63.2)
Hospital size, n (%)
Small 25,169 (13.1) 913 (12.2)
Medium 50,872 (26.4) 1757 (23.4)
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Post-operative complications, n (%)
Venous thromboembolism 5688 (2.9) 463 (6.2) < 0.0001
Wound complications 393 (0.2) 14 (0.2) 0.75
Infection 8765 (4.5) 1000 (13.3) < 0.0001
Bleeding 18,454 (9.5) 1284 (17.1) < 0.0001
Shock 320 (0.2) 16 (0.2) 0.32
Any complication, n (%) 29,326 (15.2) 2299 (30.6) < 0.0001
Discharge disposition, n (%)
Routine 139,539 (72.2) 1791 (23.8) < 0.0001
Transfer 29,515 (15.3) 3085 (41.1) < 0.0001
Home health care 21,986 (11.4) 2285 (30.4) < 0.0001
Died 2359 (1.2) 355 (4.7) < 0.0001
Hospital charges, in thousands,
median (IQR)
34.2 (21.5–56.2) 39.2 (24.7–64.4) < 0.0001
Total length of stay (days), median
(IQR)
5 (3–7) 7 (5–10) < 0.0001
Post-procedure length of stay (days),
median (IQR)
3 (1–5) 5 (3–8) < 0.0001
IQR, interquartile range
*Chi-square tests were used for categorical variables, while Wilcoxon-Rank-Sum tests were used for continuous
variables
Table 3 Crude and adjusted
effects of cholecystostomy tube
placement, compared to
cholecystectomy, on outcomes,
among elderly patients with acute
cholecystitis
Crude Adjusted*
OR (95% CI) p value OR (95% CI) p value
Post-operative complications
Venous thromboembolism 2.17 (1.97, 2.39) < 0.0001 1.65 (1.47, 1.84) < 0.0001
Wound complications 0.92 (0.54, 1.56) 0.75 0.63 (0.33, 1.20) 0.16
Infection 3.23 (3.02, 3.47) < 0.0001 2.25 (2.07, 2.45) < 0.0001
Bleeding 1.95 (1.84, 2.08) < 0.0001 1.28 (1.19, 1.37) < 0.0001
Shock 1.29 (0.78, 2.13) 0.32 0.65 (0.36, 1.15) 0.14
Any complication 2.47 (2.34, 2.59) < 0.0001 1.64 (1.55, 1.75) < 0.0001
Discharge disposition
Routine REF – REF –
Transfer 2.10 (2.04, 2.16) < 0.0001 5.78 (5.37, 6.23) < 0.0001
Home health care 2.09 (2.03, 2.16) < 0.0001 5.80 (5.39, 5.24) < 0.0001
Died 2.46 (2.34, 2.58) < 0.0001 9.27 (7.95, 10.81) < 0.0001
CIE (95% CI) p value CIE (95% CI) p value
Hospital charges, in thousands 9.33 (8.20, 10.45) < 0.0001 −2.15 (−3.32, −0.98) 0.0003
Total length of stay, in days 2.65 (2.53, 2.78) < 0.0001 0.97 (0.85, 1.10) < 0.0001
Post-procedure length of stay, in days 2.44 (2.32, 2.55) < 0.0001 1.25 (1.14, 1.37) < 0.0001
OR, odds ratio; CI, confidence interval; CIE, change in estimate
*Adjusted for type of cholecystitis, sex, age, race, insurance, income, hospital region, hospital location, hospital
size, and presence of the following comorbidities: hypertension, diabetes mellitus, obesity, renal insufficiency,
coronary artery disease, peripheral vascular disease, chronic obstructive pulmonary disease, sleep apnea, cardiac
failure, renal failure, and respiratory failure
Discussion
The management of elderly patients with acute cholecystitis is
still controversial. We aimed to compare the post-procedural
outcomes between cholecystectomy and CTP, and we found
that patients undergoing CTP had higher incidences of post-
procedural morbidity, mortality, and longer post-procedure
length of hospital stay.
Theoretically, CTP is an attractive alternative to cholecys-
tectomy. Unlike cholecystectomy, gallbladder drainage can be
performed bed-side and without need of general anesthesia. In
fact, previous studies have shown the benefits of CTP in el-
derly and comorbid patients. Horn and colleagues10 analyzed
278 consecutive patients (median age 72.5) who underwent
CTP. Indications for drainage included high burden of comor-
bid diseases and prolonged symptom duration. They reported
5% 30-day mortality, and in 55% of the cases, CTP was the
definitive treatment. Similarly, Zarour et al.11 studied 119 pa-
tients with CTP (median age 75.8) and reported seven peri-
procedural deaths (6%) and 54% were definitely managed
with CTP. Jang et al.12 also suggested that CTP was an effec-
tive and safe option in elderly patients (median age 73.8) with
acute cholecystitis (2% mortality). In our study cohort, CTP
was associated with a crude mortality of 4.7%. High post-
procedural mortality (15–17%) has been seen in other
studies.13–15 We believe that the increased mortality observed
is attributable to the fact that decompression and drainage of
the gallbladder does not equate to sepsis source control, which
may still be driven by ongoing inflammation of a necrotic
gallbladder. In addition, mortality can be related to catheter
dislodgment and/or hemorrhage.
Studies comparing CTP with cholecystectomy have
shown conflicting results. A Cochrane systematic review
including only randomized clinical trials showed no signif-
icant difference in morbidity and mortality between the
two interventions.16 Melloul et al.17 compared 23 CTP pa-
tients (median age 65) with 19 cholecystectomy patients
(median age 63), and found that overall morbidity was
9% after CTP and 47% after cholecystectomy (p = 0.01);
however, no difference was seen in mortality (13 vs. 16%,
p = 1.0). Zehetner and colleagues18 performed a retrospec-
tive single-institution study by matching 1:1 CTP and cho-
lecystectomy patients and reported no significant differ-
ence between drainage and surgical resection regarding
morbidity (17 vs. 9%, p = 0.67) and mortality (13 vs. 0%,
p = 0.23), respectively. Loftus et al.19 retrospectively ana-
lyzed patients treated at their institution (n = 42 per group),
and after matching by age, cholecystitis severity grade, and
VASQIP predicted 30-day mortality, found that CTP pa-
tients had higher 30- and 180-day mortality. Our nation-
wide analysis demonstrated that, even after adjusting for
significant comorbidities, elderly patients with acute
Table 4 Adjusted effects of
cholecystostomy tube placement,
compared to cholecystectomy, on
outcomes among elderly patients
with acute cholecystitis, stratified
by type of cholecystitis
Acalculous cholecystitis Calculous cholecystitis
OR (95% CI)* OR (95% CI)* p value
Post-operative complications
Venous thromboembolism 1.29 (1.20, 1.38) 1.26 (1.16, 1.38) 0.77
Wound complications 0.88 (0.59, 1.33) 0.60 (0.34, 1.06) 0.28
Infection 1.27 (1.19, 1.35) 1.53 (1.44, 1.61) < 0.0001
Bleeding 1.03 (0.97, 1.09) 1.15 (1.10, 1.21) 0.0027
Shock 0.74 (0.49, 1.11) 0.77 (0.51, 1.17) 0.89
Any complication 1.16 (1.11, 1.22) 1.30 (1.25, 1.35) 0.00030
Discharge disposition
Routine REF REF –
Transfer 4.74 (4.23, 5.31) 6.09 (5.52, 6.73) 0.0011
Home health care 4.92 (4.38, 5.52) 6.27 (5.67, 6.92) 0.0017
Died 7.30 (5.69, 9.38) 9.66 (7.90, 11.81) 0.082
CIE (95% CI)* CIE (95% CI)* p-value
Hospital charges, in thousands − 3.10 (− 4.78, − 1.41) − 1.35 (− 2.91, 0.20) 0.49
Total length of stay, in days 0.84 (0.66, 1.03) 1.08 (0.91, 1.25) 0.0028
Post-procedure length of stay, in days 1.31 (1.15, 1.47) 1.21 (1.06, 1.35) 0.32
OR, odds ratio; CI, confidence interval; CIE, change in estimate
*Adjusted for acalculous cholecystitis, sex, age, race, insurance, income, hospital region, hospital location,
hospital size, and presence of the following comorbidities: hypertension, diabetes mellitus, obesity, renal insuf-
ficiency, coronary artery disease, peripheral vascular disease, chronic obstructive pulmonary disease, sleep apnea,
cardiac failure, renal failure, and respiratory failure
cholecystitis still had significantly better outcomes after
undergoing cholecystectomy. CTP patients were more like-
ly to have post-operative complications and over nine
times as likely to die during their hospitalization. Post-
procedure length of hospital stay was also significantly
increased in CTP patients.
CTP is often the treatment of choice for patients with
acalculous cholecystitis.20,21 Therefore, we performed a sub-
set analysis dividing the cohort in patients with calculous and
acalculous cholecystitis. Interestingly, patients with
acalculous cholecystitis still had significantly better post-
operative outcomes after cholecystectomy, as compared to
CTP.
This study is not without limitations. The NIS does not link
hospital records, and therefore, complications, readmissions,
and mortality occurring after the initial hospital discharge can-
not be evaluated in this dataset. There is also potential for
coding errors and differences in coding practices across hos-
pitals. For instance, as there are no specific diagnostic codes
mentioning Bacalculous cholecystitis,^ the codes used to iden-
tify these patients may have included other types of cholecys-
titis. In addition, details about the severity of cholecystitis
(e.g., grade of acute cholecystitis by Tokyo guidelines) and
duration of symptoms are not provided by NIS, and thus, we
were not able to adjust for them in our analysis. Finally, this
study did not take into account the decision algorithm used by
the physician regarding the use of CTP or cholecystectomy.
There is an assumption that the reason for CTP was to benefit
frail patients from its less invasive nature. However, we have
shown that in these patients, CTP was still associated with
very high morbidity and mortality rates.
To our knowledge, this is the first study comparing out-
comes of CTP and cholecystectomy in elderly patients in a
national cohort. Considering the studies showing an increase
in use of CTP for treatment of cholecystitis in elderly
patients,8,22 we believe our results are timely and add relevant
evidence to this controversial topic.
Conclusion
Elderly patients with both acalculous and calculous acute cho-
lecystitis managed with CTP have higher incidences of post-
procedural morbidity and mortality, and longer post-
procedure length of hospital stay, compared to cholecystecto-
my. Our findings suggest that elderly patients with acute cho-
lecystitis should undergo cholecystectomy unless there are
prohibitive surgical risks.
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